GlaxoSmithKlineThe Impact of Medicines: Sustainability in Environment, Health and Safety Report 2002
Reporting Front PageDownloads
EHS 2002 home

About this report

Executive statements

Framework

Issues

Performance

Fines, penalties and serious events

Fatalities and serious occupational injuries and illnesses

EHS costs

Energy consumption

Water usage

Air emissions

Waste generation and management
Hazardous waste
Non-hazardous waste
Recycled waste
Wastewater

Health and safety

Verification statement

Index

Hazardous waste
Previous
Next
 
 

Hazardous waste disposed represents total hazardous waste generated minus the hazardous waste that has been reused, recovered or recycled. Bioengineered and biohazardous waste is included in hazardous waste. Most hazardous waste is composed of waste solvents.

In 2001 we reported 61.2 million kilograms of hazardous waste disposed. Minor adjustments were made to values reported in 2001 resulting in a baseline change to 61.3 million kilograms. In 2002, GSK disposed of 60.0 million kilograms of hazardous waste representing a 2% decrease. Nearly 80% of the total hazardous waste disposed in 2002 is solvent waste, 18% is general site waste and the remaining 2% (Other) is chemical/biological/radiological and demolition/construction wastes. In 2002, nearly half of all hazardous waste disposed (47%) was treated to obtain beneficial energy/resource recovery.

A target has been set to decrease hazardous waste disposed by 15% by the end of 2005 on a per unit sales basis.

Hazardous Waste Disposed

Hazardous Waste Disposed by Business


Previous

Next


Top


EHS 2002 Home | Reporting Front Page | Downloads | Main Site

 
Updated July 21, 2003 - © 2005 GlaxoSmithKline - All Rights Reserved
Legal Notices - Privacy Statement